Type 1 fimbriae are produced by many members of the family Enterobacteriaceae (10) and are characterized by their ability to mediate D-mannose-sensitive (MS) agglutination of guinea pig erythrocytes. The role of these fimbrial structures in mediating adherence to eucaryotic cells has led to the conclusion that type 1 fimbriae may potentiate the virulence of enterobacteria. Thus, MS fimbriae of Escherichia coli have been implicated in increasing the infectivity of uropathogenic isolates (1, 16) . Similarly, these structures have been demonstrated to play a role in the pathogenesis of infections due to Klebsiella pneumoniae (11, 20) and Salmonella typhimurium (9) . Type 1 fimbriae have also been isolated from clinical isolates of Serratia marcescens, although in this case their role in the infective process remains to be elucidated (17) . In all cases, the adherence of these fimbriae to the appropriate receptors on eucaryotic cell surfaces can be inhibited by D-mannose and related carbohydrates. However, there are serological differences between fimbrial antigens isolated from distinct members of enterobacteria as evidenced by the inability of serum prepared against fimbriae isolated from one species to react with preparations from a second species (18, 24) . Thus, these structures demonstrate a functional relatedness while retaining antigenic specificity.
More recently the molecular cloning of the gene cluster encoding the phenotypic expression of MS fimbriae of E. coli has facilitated analyses of the proteins required for the control and synthesis of these appendages (15, 25, 26) . The construction of a gene probe derived from the fimbrial gene cluster has enabled investigators to determine the degree of relatedness of DNA sequences which encode type 1 fimbriae in many different genera of bacteria (3) . These investigations revealed that there was little sequence homology between the E. coli fimbrial genes and those from other enterobacteria except Shigella species. The construction of recombinant plasmids which encode the expression of type 1 fimbriae belonging to four different genera of the Enterobacteriaceae again suggested that the genes involved in the production of * Corresponding author. fimbriae were not identical (5) . Indeed it has been shown that the phenotypic expression of type 1 fimbriae can be determined by gene sequences possessing trans-acting activity provided the genes were derived from the same bacterial species (7). Thus, no complementation to restore fimbrial expression, between genes derived from different species, was observed. These data suggest that the gene clusters encoding type 1 fimbriae have undergone considerable divergence in terms of sequence homology; also, the gene products interact in specific ways to assemble these appendages. Consequently, it would be of interest to compare the genetic organization of fimbrial determinants from distinct bacterial species and to determine what degree of similarity is found among polypeptides encoded by these genes. In this paper we describe the initial studies on the organization of fimbrial genes from K. pneumoniae, S. typhimurium, and S. marcescens.
MATERIALS AND METHODS
Media, growth conditions, and bacteria. E. coli ORN103 (kindly provided by P. E. Orndorff) is a genotypically nonfimbriate strain derived from the minicell producer E. coli P678-54 (27) and was used in all transformation experiments involving recombinant plasmids. The transformants exhibiting MS hemagglutinating activity (MSHA) are shown in Table 1 .
Unless otherwise stated, bacterial cultures were grown in Luria broth or in Luria agar (22) for 18 to 24 h at 37°C, and culture media were supplemented with the appropriate antibiotics at the following concentrations: ampicillin, 100 ,ug/ml; tetracycline, 20 ,g/ml, and chloramphenicol, 25 ,ug/ml (200 ,ug/ml for plasmid amplification). Spectinomycin (200 ,ug/ml) was used for the amplification of plasmids conferring chloramphenicol resistance.
Bacterial plasmids. Plasmids pISF101, pMH2, and pBP7, encoding the expression of type 1 fimbriae of S. typhimurium, S. marcescens, and K. pneumoniae, respectively, have been described in detail elsewhere (5, 28 Deletion mutants of appropriate plasmids were constructed after digestion with specific restriction endonucleases or the exonuclease Bal 31. Plasmid DNA was purified from amplified cells by sodium dodecyl sulfate (SDS) lysis and ethidium bromide-cesium chloride equilibrium density gradient centrifugation (13, 29) . Rapid analysis of transformants for the presence of plasmid DNA was performed by the technique of Holmes and Quigley (14) .
The conditions for isolation and ligation of DNA fragments and restriction enzyme digestion and agarose electrophoresis have been described elsewhere (4, 28) .
Preparation and labeling of minicells. Minicells were prepared as previously described (6), and plasmid-encoded polypeptides were labeled with a mixture of [35S]methionine and 14C-labeled amino acids (Amersham Corp.). Labeling was allowed to proceed for 2 to 4 h before the removal of unincorporated amino acids by centrifugation. The radiolabeled gene products were detected by autoradiography (2) after electrophoresis through 12.5% SDS-polyacrylamide gels.
For immune precipitation, minicell extracts were prepared after sonication and centrifugation followed by the addition of an equal volume (100 RI) of 0.05 M Tris (pH 7.5)-2 M potassium chloride-2% Triton X-100. Undiluted fimbrial antiserum (50 RI) was added, and the reaction mixture was incubated at 4°C overnight. Antigen-antibody complexes were precipitated by goat anti-rabbit IgG (50 p.I) after a second overnight incubation at 4°C. These precipitates were isolated by centrifugation, and the pellet was subsequently washed once with 0.05 M Tris (pH 7.5)-1.2 M KCl-1.2% Triton X-100 followed by 0.05 M Tris-0.1 NaCl. Samples were dissolved in SDS electrophoresis sample buffer and run through 12.5% SDS-polyacrylamide gels.
Purification of type 1 fimbriae. A single procedure which could be used for the purification of type 1 fimbriae from all strains of bacteria was not established. Thus, MS fimbriae from a clinical isolate of S. typhimurium were prepared by the method of Dodd and Eisenstein (8) , whereas the K. pneumoniae fimbriae were purified by the scheme of Fader et al. (12) . The type 1 fimbriae of S. typhimurium were also prepared with deoxycholate and urea as previously described (18) ; this procedure was also used to prepare the fimbriae of S. marcescens. The purity of each preparation was assessed by SDS electrophoresis after boiling of the sample at a pH of 1.8.
Sera raised against fimbrial antigens were prepared after immunization of New Zealand White rabbits. An initial injection of antigen was given subcutaneously, followed by three intramuscular administrations of immunogen each 4 days apart. Antibodies directed against fimbrial antigens were detected by agglutination of fimbriate-phase bacterial suspensions, and hyperimmune sera were used for the immunoprecipitation studies.
Expression of type 1 fimbriae. The phenotypic expression of type 1 fimbriae by bacteria was determined by observation of the strains under the electron microscope (4). Hemagglutination tests were performed using a fresh 3% (vol/vol) suspension of guinea pig erythrocytes in the presence and absence of D-mannose (5). Fimbrial antigens were detected on the bacteria by standard serological agglutination tests or hemagglutination inhibition reactions (5).
RESULTS
Expression of type 1 fimbriae by the minicell-producing strain of E. coli. It has previously been reported by us that transformants of E. coli HB101 were found to express type 1 fimbriae of different serological specificities. Similarly, the genotypically pil-, minicell-producing strain E. coli ORN103 could be transformed by the appropriate plasmids to produce type 1 fimbriae possessing hemagglutinating activity (Table  1) . Unlike E. coli HB101, the ORN103 strain has previously been shown to lack DNA sequences homologous to the pil gene cluster of E. coli (25) . Transformants appeared fully fimbriate when examined by electron microscopy and exhibited the characteristic MSHA activity associated with type 1 fimbriae. Hemagglutination by these transformants could be inhibited only by homologous antisera; therefore, these results are in agreement with those obtained with E. coli HB101 (7) .
The type 1 fimbriae were purified from both of the strains containing recombinant plasmids and also from the original wild-type parental isolates. Regardless of the source, the molecular sizes of the fimbrial subunits derived from one species were identical. Thus, the subunit molecular sizes of the Salmonella, Serratia, and Klebsiella fimbriae were 21.5, 16.5, and 19.5 kilodaltons (kDa), respectively ( Fig. 1 ). Preparations of S. typhimurium type 1 fimbriae occasionally showed the presence of a smaller 20.0-kDa polypeptide after electrophoresis ( Fig. 1) . All samples were shown, by electron microscopy, to consist of fimbrial filaments and appeared devoid of any contaminating membrane components.
Fimbrial preparations exhibited MSHA when tested in microtiter plates (5), except for preparations of fimbriae which had been exposed to high concentrations of urea (8) . In such cases, the purified fimbriae retained the intact fimbrial morphology but did not agglutinate guinea pig erythrocytes. Gene products involved in fimbrial expression. The parental plasmids pISF101, pMH2, and pBP7 are recombinant molecules which encode type 1 fimbrial expression by S. typhimurium, S. marcescens, and K. pneumoniae, respectively (5). Deletion mutants were constructed after digestion of these plasmids with either specific restriction enzymes or the exonuclease Bal 31. The deletion mutations along with the hemagglutinating phenotype of corresponding transformants are shown in Fig. 2 .
The minicells possessing the parental plasmid pISF101 express at least six polypeptides which appear to be involved in Salmonella fimbrial synthesis and assembly (Fig. 3) . The molecular sizes of these polypeptides were estimated to be 82.0, 37, 30, 26, 25, and 21.5 kDa, and the locations of the genes encoding these polypeptides (except the 82-kDa protein) are represented in Fig. 2 . For example, the 21.5-kDa polypeptide is encoded by only those recombinant plasmids retaining a 3.0-kilobase SphI-EcoRI DNA fragment which is located on pISF101 (Fig. 2) Three detectable polypeptides were associated with type 1 fimbrial production in S. marcescens, and the genes encoding these polypeptides were mapped on pMH2 (Fig. 2) . The + + electrophoretic mobilities of these gene products indicated their molecular sizes to be 82, 59, and 16.5 kDa. Mutants -.. which lacked the ability to produce any one of these polypeptides failed to express hemagglutinating fimbriae on their surface. The presence of a 64-kDa polypeptide produced by some of the mutants (pMH14, pMH17, and pMH20; Fig. 4 (Fig. 6) . The meo ajo oftimbfrialgsubnit gene ofP S.ul typhimurium weas fondtoa eencodeecthe2it-D proly ipeptide, beauertiswa tuhe olyre pelasmidoncodednhi poyeptide ofg.pBP903, which r)seaed with the Sralmnellambantifmrialt seru.5Thisgene product posseneessedany idntcaeainectrophordenticfoilityo tofheeecdn the fimbrialsubunitso.h bohmial purfie atgen.rdut Simiary thmue serumraised against thepui Seraiadfimbriae prtiecipitatedfonl one gen-tye product of pMH2m. anThisgn product exhibited an moleculcar mobilty,ho retic mobilityto the fimbrial subu~nito h iceial 82iidatgn-imlry h eu rie gis h Serratia~fibiepeiiae nl n eepouto pM2 n hs rdc xibtdamlcuaJoiiy equivalent to the 16.5-kDa polypeptide, that was identical to that of the purified subunit. Serum raised against type 1 fimbriae purified from K. pneumoniae reacted with a 19.5-kDa polypeptide, and the electrophoretic mobility of fimbriae purified from the K. pneumoniae was identical to that of a 19.5-kDa polypeptide. Due to the similarity of the physical maps of recombinant plasmids encoding type 1 fimbriae of E. coli and K. pneumoniae (5) and the reported cross-reactivity between these antigens with immune sera (24) , the location of the fimbrial subunit gene on pBP7 was determined by using a DNA probe encoding the E. coli type 1 fimbriae. Thus a radiolabeled probe derived from pSH2 (3) (kindly provided by S. Hull) which consisted partly of nucleotide sequences comprising the fimbrial subunit gene was constructed by restriction enzyme digestion and nick translation (21) . This probe, which was an EcoRI-RstI fragment of pSH2, contains DNA sequences encoding the C-terminal portion of the E. coli pilA structural gene as well as a segment of the pilB gene (25) . The probe hybridized only to a 1.7-kilobase PstI-EcoRI fragment of pBP7, indicating a possible homology in the nucleotide sequence of the genes encoding the fimbrial subunits of E. coli and K. pneumoniae. This region of homology was distinct from the 641-base-pair ClaI fragment; thus, pBP7 encodes two different 19.5-kDa polypeptides. One of these is the major fimbrial subunit, whereas the other polypeptide would appear to be involved in the expression of the subunit itself.
DISCUSSION
The genetic cluster encoding the type 1 fimbriae of E. coli has facilitated the investigation of the control and expression of these organelles in this species (25) (26) (27) . Recently, we demonstrated that the fimbrial genes of distinct enteric bacteria may not be identical because of differences in the restriction enzyme maps of the cloned determinants and also the inability of genes derived from different species to complement each other to restore hemagglutinating activity (5, 7). Certainly, differences in the genes encoding the fimbrial subunit of enteric bacteria may be expected as evidenced by the lack of serological relatedness of the fimbrial antigens (18, 24) which may reflect a difference in the amino acid sequence of the subunit. The results of this study indicate that the phenotypic expression of type 1 fimbriae by species belonging to the genera Klebsiella, Salmonella, and Serratia is due to the presence of a number of gene products. Such results are consistent with those previously reported for the expression of both type 1 (25) and mannose-resistant (6, 19) fimbriae of E. coli. Thus, within the family Enterobacteriaceae, the biogenesis and expression of fimbrial appendages is a complex process requiring multiple gene products. However, the primary structure of these gene products and the organization of fimbrial gene clusters also differ among genera. As many as six polypeptides are implicated in the expression of type 1 fimbriae by S. typhimurium, whereas four polypeptides were found for K. pneumoniae. In some cases, the absence of one polypeptide was associated with the concomitant absence of a second accessory gene product or occasionally with the increased production of other polypeptides. For example, in the Salmonella system, only the deletion derivative pISF107 was found to encode increased amounts of a 37-kDa poly- peptide and, also, a small (<16-kDa) gene product (Fig. 3) . Thus, it is possible that the accumulation of the 37-kDa protein is due to the absence of expression of the complete fimbrial gene cluster. Therefore, a complex interrelationship may exist among the elements involved in fimbrial expression. Due to the nature and extent of the deletion in pISF107, the presence of the lower-molecular-weight polypeptide is consistent with this being a truncated form of the 25-kDa protein.
Although the organization of the type 1 fimbrial gene clusters appears to be different with respect to location and sizes of gene products, there are some similarities between these genetic elements and that of the E. coli system, especially in the case of K. pneumoniae. For example, all systems reported in this study possess a high-molecularweight polypeptide (Fig. 2 ) similar to that identified in E. coli by Orndorff and Falkow (25) (Fig. 2) , encodes a second 19.5-kDa gene product distinct from that of the processed fimbrial protein. This conclusion is supported by the fact that the gene product of the deletion plasmid pBP713, carrying the 641-base-pair ClaI fragment (Fig. 2) , does not react with fimbrial antiserum. Deletion of only the small ClaI fragment of pBP7 resulted in the inability of the remainder of the molecule to produce viable transformants. This lethal effect could be overcome by the synthesis of larger deletions extending into the putative fimbrial structural gene and; the possibility of the 19.5-kDa polypeptide suppressing the fimbrial subunit gene is being explored. A polypeptide which suppresses fimbrial expression in the E. coli system has been described; although mutants lacking this gene product were viable, the resulting transformants exhibited a small colony phenotype (26) . However, because the deletions described above were DNA sequences residing on a high-copy-number plasmid, it is also possible that the lethal effect of deletions in the small ClaI fragment are due to more indirect effects of gene dosage. Further experiments are currently being performed to determine the physiological role of this gene product.
In most instances the locations of the genes on recombinant plasmids were determined by analysis of appropriate deletion derivatives. However, the precise site of two closely linked genes was sometimes difficult to determine. For example, the relative locations of the genes on pISF101 encoding the 25-and 26-kDa polypeptides must be considered preliminary. In some cases it was not possible to accurately map the position of the genes encoding specific polypeptides encoded by the recombinant plasmids (e.g., the 82-kDa polypeptide of the Salmonella system). However, we believe that these genes are involved in fimbrial expression because they are carried on DNA fragments which are contained within the length of DNA essential for the expression of the Fim+ MSHA-positive phenotype as previously determined by transposon mutagenesis (5) . Alternatively, these genes are not part of the fimbrial system but are, in some cases, flanked by determinants implicated in fimbrial biosynthesis; we consider this to be unlikely. In the case of S. marcescens only four plasmid encoded polypeptides could be determined by the minicell system. The position of the genes encoding these proteins indicates that other genes may be involved in fimbrial expression. Indeed, we have previously shown that insertions of the transposable element Tn5 into regions of DNA distinct from those encoding the polypeptides result in elimination of the hemagglutinating phenotype (7) . Therefore, such fragments of DNA may contain genes encoding proteins which are produced in relatively small quantities.
Recent evidence has suggested that the gene encoding the type 1 fimbriae of E. coli is distinct from that encoding the adhesive function (23) . In our studies all strains possessing the parental plasmids pBP7, pMH2, and pISF101 were found to be fimbriate when examined by electron microscopy and exhibited MSHA. However, most of the transformants possessing the deletion derivatives of these recombinant molecules were screened only for hemagglutinating activity. Consequently, some of the hemagglutination-negative strains may in fact be phenotypically fimbriate. Currently, we are using the strains described in this paper to determine the relationships among the fimbrial genes of enteric bacteria and also to determine whether a related MS adhesive component is found among these bacteria.
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